The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 21, 2022
Filed:
Apr. 27, 2020
Applicants:
Thomas Jefferson University, Philadelphia, PA (US);
Ramot AT Tel-aviv University Ltd., Tel Aviv, IL;
Inventors:
Nir Ben-Tal, Tel Aviv-Jaffa, IL;
Roger S. Armen, Philadelphia, PA (US);
Laurence C. Eisenlohr, Merion Station, PA (US);
Jitendra Belani, Paoli, PA (US);
Michael Miller, Philadelphia, PA (US);
Inbar Fish, Sunnyvale, CA (US);
Ori Kalid, Pardes Hanna, IL;
Assignees:
Thomas Jefferson University, Philadelphia, PA (US);
Ramot At Tel-Aviv University LTD., Tel Aviv, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/16 (2006.01); C07C 311/29 (2006.01); A61K 31/63 (2006.01); A61K 31/18 (2006.01); A61K 31/352 (2006.01); A61K 31/167 (2006.01); A61K 31/04 (2006.01); A61P 31/16 (2006.01);
U.S. Cl.
CPC ...
C07C 311/16 (2013.01); A61K 31/04 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/352 (2013.01); A61K 31/63 (2013.01); A61P 31/16 (2018.01); C07C 311/29 (2013.01);
Abstract
An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.